Navigation Links
HeartView Global Foundation honors World-Renowned Cardiologist, Asher Kimchi and Philanthropist Diane Brinson
Date:2/23/2013

Westlake Village, CA (PRWEB) February 23, 2013

Pioneering cardiologist, Asher Kimchi, MD, Clinical Chief of the Division of Cardiology and Medical Director of the Preventive and Consultative Heart Center of Excellence at the Cedars-Sinai Heart Institute in Los Angeles; and Diane Brinson, an insurance entrepreneur who founded a brokerage to serve high net worth individuals and businesses, were honored at the second annual HeartView Global Foundation dinner and live charity auction held on February 16, 2013, at the Four Seasons Hotel in Westlake Village.

Kimchi, clinical professor of medicine, received the Foundation’s award for Excellence in Early Detection and Prevention of Cardiovascular Disease. A native of Tel Aviv, Israel, Kimchi is an internationally recognized clinical cardiologist, former flight surgeon in the Israeli Air Force and the founder and chairman of the International Academy of Cardiology and the World Congress on Heart Disease. Author of numerous books and original manuscripts, Kimchi has been honored with the Passion of the Heart Award from the American Heart Association, Western States Affiliate and was recently elected as a Fellow of the International Academy of Cardiovascular Sciences, an honor given to only 250 physicians and scientists worldwide.

Diane Brinson, who received the organization’s top philanthropic award, founded Momentous Insurance Brokerage in 2008. Brinson guided its growth to 140 employees and 2012 revenues of $27 million, making it the fourth-largest woman-owned business in the San Fernando Valley. Today, Momentous employees are encouraged to contribute a portion of their paychecks to charity, and the company provides a dollar-for-dollar match. Mrs. Brinson was honored with HeartView Global Community Award for Excellence in Leadership and Dedication to Early Detection and Prevention of Cardiovascular Disease.

“Dr. Kimchi and Diane Brinson epitomize what our mission is all about: Expert medical care coupled with compassionate and considerate support,” said Jonathan Schwartz, founder and president of HeartView Global Foundation. “Dr. Kimchi’s knowledge of cardiac medicine, along with his genuine, caring personality explain why his patients are so dedicated to him. And Diane Brinson’s generosity is helping to ensure that patients will get the care they need, regardless of cost.”

Comedian Greg Fitzsimmons, who hosts a daily program on Sirius satellite radio, emceed the gala with his irreverent humor. It was a memorable evening that also featured rousing performances by pop singer, Mateo, country-pop artist Joel Crouse and veteran singer-songwriter-musician Richard Marx (“Endless Summer Nights,” “Right Here Waiting” and “Don’t Mean Nothing”).

The Gala was attended by 400 of the most high-powered names in entertainment, business and sport, including Walt Disney Studios Chairman, Alan Horn and his wife, Cindy Horn an environmental and public health advocate; David H. Murdock, Chairman of Dole Food Company and majority owner of the California Health and Longevity Institute in Westlake Village; NFL quarterback, Jimmy Clausen and NFL running back, Brandon Jackson. Alanis Morissette is among the supporters of the event.

HeartView Global Foundation is a non-profit organization created for the purpose of identifying patients with asymptomatic coronary artery disease for whom preventive measures can be taken to avoid heart attacks, strokes and sudden cardiac death. In addition to supporting research led by Daniel Berman, MD, at Cedars-Sinai in heart attack prevention, the Foundation funds are used to allow patients who need testing to get a coronary CT angiogram, the most accurate test for determining the risk of heart attack. While proven in a large, consistent body of evidence and covered in many states, this highly effective, noninvasive method for evaluation of these patients is not covered by most medical insurance in California. For many at-risk patients, the out-of-pocket payment for this test may be out of reach. The Foundation has generously established a fund at Cedars-Sinai that allows testing of selected patients who need the test but cannot afford it.

Schwartz is a partner in GSO Business Management, a Sherman Oaks-based financial practice that serves the entertainment industry, high net worth individuals and companies. He founded HeartView after his childhood friend died at age 42 from a sudden heart attack. The loss motivated Schwartz, who has a family history of heart disease, to see a doctor and undergo a coronary CT scan, which revealed a life-threatening blockage in a major artery into his heart.
“My friend's passing and a coronary CT scan saved my life, and now I want to help improve and possibly save the lives of thousands of people,” Schwartz said.

For more information, or to make a donation,
please visit HeartView Global Foundation.
Contact: Jonathan Schwartz
(818) 462-5678
jschwartz(at)gsogroup.com

Read the full story at http://www.prweb.com/releases/2013/2/prweb10458633.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Cedars-Sinai Heart Institute Physician Asher Kimchi, M.D., Insurance Entrepreneur Dianne Brinson to be Honored at HeartView Global Foundation’s Second Annual Gala
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Canada should play a role in addressing the global cancer epidemic
4. Global cardiology leaders meet in Dubai
5. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
6. International breast health global summit will focus on supportive care and quality of life
7. Scientists rewrite rulebook on breast cancer in landmark global study
8. Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology
9. Centre for Global Non-Communicable Diseases launched to tackle killer diseases
10. UCLA researchers combat global disease with a cell phone, Google Maps and a lot of ingenuity
11. New study identifies how information technology is used to solve global health challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound energy ... ... Jim Bertolina, PhD ... Tom Tefft ... executive Josh Stopek , PhD, who has led R&D and business development teams at ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
Breaking Medicine Technology: